Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (Diabetologia, (2023), 66, 2, (300-309), 10.1007/s00125-022-05824-0)

Katherine G. Young; Andrew P. McGovern; Inês Barroso; Andrew T. Hattersley; Angus G. Jones; Beverley M. Shields; Nicholas J. Thomas; John M. Dennis

ArticleOPEN ACCESS

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (Diabetologia, (2023), 66, 2, (300-309), 10.1007/s00125-022-05824-0)

Diabetologia

DOI: 10.1007/s00125-023-05933-4

0Citations

9Readers

Abstract

The duration of follow-up of the UK Biobank participants was erroneously given as 10 years instead of 12 years in the text. The original article has been corrected.

Cite

CITATION STYLE

APA

Young, K. G., McGovern, A. P., Barroso, I., Hattersley, A. T., Jones, A. G., Shields, B. M., … Dennis, J. M. (2023, August 1). Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (Diabetologia, (2023), 66, 2, (300-309), 10.1007/s00125-022-05824-0). Diabetologia. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00125-023-05933-4

Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (Diabetologia, (2023), 66, 2, (300-309), 10.1007/s00125-022-05824-0)

Abstract

Cite

Register to see more suggestions